MyFinsight
Home
Blog
About
Proceeds from issuance of
series e convertible...
$1,000,000
Net cash provided by
financing activities
$940,001
Canceled cashflow
$59,999
Increase (decrease) in
cash and cash...
$327,041
Canceled cashflow
$612,960
Offering costs
$59,999
Stock based
compensation
$371,300
Loss on issuance of
convertible note
$322,359
Amortization of debt discount
$275,213
Accrued liabilities
$172,565
Issuance of common stock
for services
$81,500
Prepaid expenses and
other assets
-$48,213
Accounts payable
$46,324
Depreciation and
amortization
$12,304
Deferred revenue
$12,235
Amortization of license fees
$7,500
Net cash used in
operating activities
-$605,460
Net cash used in
investing activities
-$7,500
Canceled cashflow
$1,349,513
Net loss
-$1,506,344
License agreement
$7,500
something is missing
-$348,993
Accounts receivable
$90,005
Inventory
$6,513
Amortization of right-of-use
assets, net of...
$3,118
Back
Back
Cash Flow
20 20 Biolabs, Inc. (AIDX)
20 20 Biolabs, Inc. (AIDX)
source: myfinsight.com